BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya BeiGene has licensed a MAT2A inhibitor from a subsidiary of Chinas CSPC Pharmaceutical Group for $150 million upfront
The label says the vial should be inspected for particulate matter and discoloration before use if the container allows
In a 2024 review of three peptides, the FDA noted side effects like increased heart rate, chest tightening, headache, nausea, diarrhea, and elevated liver enzymes, as well as skin irritation and pain at the injection site
Stay hydrated, eat nutrient-rich foods, brush/floss daily, use fluoride, chew sugar-free gum, and schedule regular cleanings